Skip to content

Stock Screener

/
Drug Manufacturers - General
$991.62B
$72.25B+47.4%
28.15+129%
39.2x13.7x82.8%35.0%
Drug Manufacturers - General
$563.77B
$96.36B+7.9%
8.64-3.9%
26.8x5.8x67.8%21.8%
Medical - Healthcare Plans
$362.83B
$449.71B+9.7%
13.25-44.5%
30.1x0.8x88.6%2.7%
Drug Manufacturers - General
$285.12B
$65.77B+2.9%
3.56-48.2%
31.9x4.3x73.9%13.6%
5
Amgen logo
Amgen
AMGN
Drug Manufacturers - General
$184.40B
$37.22B+9.1%
14.38+31.2%
23.6x5.0x68.3%21.0%
Medical - Diagnostics & Research
$171.57B
$43.36B+2.4%
18.19+6.7%
25.1x4.0x58.3%15.2%
Drug Manufacturers - General
$155.75B
$29.74B+3.5%
7.34+54.5%
16.9x5.2x79.4%31.0%
8
Abbott logo
Medical - Devices
$154.15B
$45.13B+6.6%
3.58-53.5%
24.6x3.4x56.3%13.9%
9
Pfizer logo
Drug Manufacturers - General
$147.73B
$63.32B+1.4%
2.12+50.3%
12.2x2.3x73.5%15.7%
Medical - Instruments & Supplies
$142.44B
$10.58B+21.4%
8.24+20.6%
47.8x13.5x66.3%28.2%
Medical - Healthcare Plans
$126.52B
$407.91B+7.6%
2.29-45.5%
43.1x0.3x44.7%0.7%
12
Danaher logo
Medical - Diagnostics & Research
$125.81B
$24.78B+4.0%
5.17+0.4%
34.1x5.1x58.9%14.9%
Biotechnology
$116.49B
$12.22B+10.1%
16.85+625%
26.9x9.5x86.2%35.5%
14
Stryker logo
Medical - Devices
$115.45B
$25.27B+8.8%
8.64+16.8%
34.6x4.6x63.8%13.2%
Drug Manufacturers - General
$112.89B
$48.48B+1.8%
3.56+35.4%
15.5x2.3x70.5%15.0%
Medical - Devices
$100.32B
$36.36B+8.4%
3.74+3.3%
20.9x2.8x64.9%13.0%
Medical - Distribution
$91.3B
$403.43B+12.4%
38.41+49.2%
19.2x0.2x3.6%1.2%
Medical - Healthcare Plans
$85.0B
$200.42B+9.3%
23.58-8.2%
16.2x0.4x89.2%2.6%
19
Cigna logo
Medical - Healthcare Plans
$75.4B
$277.89B+8.8%
23.61+31.2%
12.2x0.3x20.6%2.2%
Medical - Devices
$66.8B
$20.62B+17.4%
2.39+74.5%
18.8x3.2x69.2%17.3%
Biotechnology
$63.7B
$14.92B+5.9%
41.05+4.4%
14.4x4.3x93.9%29.6%
22
Cencora logo
Medical - Distribution
$53.9B
$328.68B+5.9%
18.47+162%
14.9x0.2x3.8%0.6%
Medical - Distribution
$53.0B
$250.74B+12.8%
6.55+2.3%
34.1x0.2x3.8%0.6%
Medical - Devices
$49.9B
$6.3B+14.1%
1.88-73.1%
45.5x7.9x77.9%17.4%
25
Humana logo
Medical - Healthcare Plans
$43.5B
$137.2B+14.1%
26.26+17.1%
13.7x0.3x3.0%